Pfizer files for emergency use of coronavirus vaccine in U.S. — what about in Canada?  Global NewsView Full coverage on Google News
Pfizer applied to Health Canada for approval of the vaccine on Oct. 9, according to the department's website and has been subject to a 'rolling' review since.Pfizer applied to Health Canada for approval of the vaccine on Oct. 9, according to the department's website and has been subject to a 'rolling' review since.

Pfizer files for emergency use of coronavirus vaccine in U.S. — what about in Canada? - National | Globalnews.ca

From debunking misinformation about mRNA vaccine technology to how COVID-19 vaccinations would be prioritized for more than 35 million Canadians, here are some answers — as well as clarity on what we don't yet know.From debunking misinformation about mRNA vaccine technology to how COVID-19 vaccinations would be prioritized for more than 35 million Canadians, here are some answers — as well as clarity on what we don't yet know.

Our recap of important vaccine news this week, from the apparent confusion around how many doses Canada is getting and when, to how a country music ic...Our recap of important vaccine news this week, from the apparent confusion around how many doses Canada is getting and when, to how a country music ic...

Trump accused U.S. drugmaker Pfizer of waiting to announce the success of their Phase 3 vaccine trial until the day after the presidential election in order to avoid helping him.Trump accused U.S. drugmaker Pfizer of waiting to announce the success of their Phase 3 vaccine trial until the day after the presidential election in order to avoid helping him.

Trump turns on Pfizer over vaccine timing

American pharmaceutical company Pfizer is seeking approval for the emergency use of its coronavirus vaccine in the US. Early results show the vaccine appears 95 per cent effective at preventing mild to severe cases of COVID-19. The company says it should qualify for emergency use authorisation before final testing is fully complete. It's already started "rolling" applications in Europe and the UK. Meanwhile, US officials have warned Americans not to travel ahead of Thanksgiving. A resurgence of COVID-19 cases across the country has forced some states into lockdown, closing businesses and schools.American pharmaceutical company Pfizer is seeking approval for the emergency use of its coronavirus vaccine in the US. Early results show the vaccine appears 95 per cent effective at preventing mild to severe cases of COVID-19. The company says it should qualify for emergency use authorisation before final testing is fully complete. It's already started "rolling" applications in Europe and the UK. Meanwhile, US officials have warned Americans not to travel ahead of Thanksgiving. A resurgence of COVID-19 cases across the country has forced some states into lockdown, closing businesses and schools.

News, analysis and comment from the Financial Times, the worldʼs leading global business publication

Subscribe to read | Financial Times

Each time we learn about a potential Covid vaccine, there is jubilation throughout the globe. Perhaps, the most widely and closely tracked things in the world now are the most promising vaccines. Though the Oxford-led consortium had an early advantage in the race to finding an effective vaccine for convenient mass-immunisation, now it seems that Pfizer and Moderna haveEach time we learn about a potential Covid vaccine, there is jubilation throughout the globe. Perhaps, the most widely and closely tracked things in the world now are the most promising vaccines.

Covid vaccines again expose global inequity | The Daily Star

President Trump hurts the American people when he acts to deprive drug companies of earnings they need to develop new drugs and treatments. And he presents no evidence for his claim that drug companies delayed announcing progress on coronavirus vaccines to hurt his reelection chances.President Trump hurts the American people when he acts to deprive drug companies of earnings they need to develop new drugs and treatments. And he presents no evidence for his claim that drug companies delayed announcing progress on coronavirus vaccines to hurt his reelection chances.

The president accused drugmaker Pfizer of waiting to announce the success of its phase III vaccine trial until the day after the Nov. 3 election in order to avoid helping him.The president accused drugmaker Pfizer of waiting to announce the success of its phase III vaccine trial until the day after the Nov. 3 election in order to avoid helping him.

TITLE: Trump: Pfizer and other drug companies delayed vaccine information deliberately

Florida added another 9,000 COVID-19 cases Friday, bringing the total to more than 914,000 in the state since the start of the pandemic.Florida added another 9,000 COVID-19 cases Friday, bringing the total to more than 914,000 in the state since the start of the pandemic.

Florida stands ready to receive COVID-19 vaccines

This is a watershed moment where all of us must recognise that no one’s health is fully protected until all of us areThis is a watershed moment where all of us must recognise that no one’s health is fully protected until all of us are

We are facing an unprecented global challenge to protect every country from Covid-19

It’s possible the vaccine actually prevented infection, and not just the resulting illness, but the results so far don’t show that, experts say

'Not going to end the pandemic': Why those hopeful vaccine trial results are not all that they seem | National Post

'Not going to end the pandemic': Why those hopeful vaccine trial results are not all that they seem | National Post

Pfizer Inc. filed with U.S. regulators for an emergency-use authorization for its Covid-19 vaccine, seeking clearance for an experimental shot that’s expected to play an important role in an immunization effort to halt the virus.

Pfizer COVID vaccine first to seek emergency U.S. approval - BNN Bloomberg

Last week, airline and pharma stocks jumped over 20% when Pfizer's COVID-19 vaccine showed 90% effectiveness. Should you buy on these hopes? Last week, airline and pharma stocks jumped over 20% when the Pfizer COVID-19 vaccine showed 90% effectiveness. Should you buy the stocks on these hopes?

Pfizer Vaccine Shows Impact on TSX Stocks! - The Motley Fool Canada

Moderna will charge governments between $25 and $37 per dose of its COVID-19 vaccine candidate, depending on the amount ordered, Chief Executive Stephane Bancel told German weekly Welt am Sonntag (WamS).Moderna will charge governments between $25 and $37 per dose of its COVID-19 vaccine candidate, depending on the amount ordered, Chief Executive Stephane Bancel told German weekly Welt am Sonntag (WamS).

Moderna to charge $25-$37 for COVID-19 vaccine: CEO tells paper | Reuters

Pfizer and BioNTech confirmed they will file with the FDA for emergency use authorization on Friday, after announcing the final Phase 3 coronavirus vaccine results a few days ago. The experimental drug proved to be highly effective in the final testing stage, and it had minimal side effects.Pfizer and BioNTech confirmed they will file with the FDA for emergency use authorization on Friday, after announcing the final Phase 3 coronavirus vaccine results a few days ago. The experimental …

The end of the coronavirus pandemic is in sight – BGR

Here are the next steps in the approval and distribution processHere are the next steps in the approval and distribution process

COVID-19 vaccine: the next steps | Americas – Gulf News

The European Union could pay more than $10 billion to secure hundreds of millions of doses of the vaccine candidates being developed by Pfizer-BioNTech and CureVac, an EU official involved in the talks told Reuters.The European Union could pay more than $10 billion to secure hundreds of millions of doses of the vaccine candidates being developed by Pfizer-BioNTech and CureVac, an EU official involved in the talks told Reuters.

EU could pay over $10 billion for Pfizer and CureVac vaccines, says source | News | ekathimerini.com

By Hari Kumar The race for a vaccine against Covid-19 is entering the home stretch and reports indicate one or more companies will soon get the go-ahead to begin mass production. Governments across the world have promised their citizens speedy access but the task facing authorities in transporting, storing and administering the doses is enormous. […]

Now the hard part: Why getting Covid vaccines to billions worldwide may take longer than hoped | Hong Kong Free Press HKFP

Middle East News: RIYADH: The Saudi Arabian government has committed more than $500 million to funding efforts to develop and produce a safe and effective vaccine again.Middle East News: RIYADH: The Saudi Arabian government has committed more than $500 million to funding efforts to develop and produce a safe and effective vaccine again.

Saudi Arabia commits $500 million to Covid-19 vaccine development - Times of India

The pandemic could end soon for rich countries — but not for developing ones. This is Big Pharma's doingThe pandemic could end soon for rich countries — but not for developing ones. It's the pharmaceutical industry's fault

Big Pharma could supply the whole world with a COVID vaccine. They've chosen not to | Salon.com

Moderna transformed from a hot biotech startup to one of the world's best-known companies as it pursues a coronavirus vaccine.Moderna transformed from a hot biotech startup to one of the world's best-known companies as it pursues a coronavirus vaccine.

How Moderna developed a coronavirus vaccine in record time - Business Insider

Because Pfizer-BioNTech and Moderna vaccines have been developed in record time, many wonder whether companies cut corners or compromised safety.Because Pfizer-BioNTech and Moderna vaccines have been developed in record time, many wonder whether companies cut corners or compromised safety.

COVID-19 vaccines were developed in record time – but are these game-changers safe?

COVID-19 vaccines were developed in record time – but are these game-changers safe?

Pedestrians walk past Pfizer world headquarters in New York. (AP Photo)Pedestrians walk past Pfizer world headquarters in New York. (AP Photo)

The coming of the COVID-19 vaccines and what they mean | Arab News

THE CORONAVIRUS vaccine created by Pfizer should be rolled out in the UK from December 2020. Will the vaccine be mandatory for international travel?THE CORONAVIRUS vaccine created by Pfizer should be rolled out in the UK from December 2020. Will the vaccine be mandatory for international travel?

Will Covid vaccine be mandatory for international travel? | Travel News | Travel | Express.co.uk

Pfizer and Moderna both have COVID-19 vaccines that seem to work 95% of the time. But even with a vaccine on the horizon, the pandemic is far from over. New data shows both vaccines working about 95% percent of the time. But for the vaccines and the pandemic, this is far from the end.

Two COVID-19 vaccines are working. So what comes next?

Pfizer and BioNTech have submitted their covid-19 vaccine candidate to the US Food and Drug Administration (FDA) for emergency use authorisation, after concluding a phase III trial. The mRNA vaccine candidate, BNT162b2, was found to be 95% effective 28 days after the first dose. The phase III trial evaluated 170 confirmed cases of covid-19, 162 of which were observed in the placebo group. There were 10 severe cases, nine of which were in the placebo group. In its announcement, Pfizer said the vaccine could be available to high risk populations in the US by the end of December 2020. Globally, it plans to produce 50m doses in 2020 and up to 1.3bn doses by the end of 2021. The companies have started submission processes in Europe, as well as Australia, Canada, and Japan. The phase III trial began …

Covid-19: Pfizer and BioNTech submit vaccine for US authorisation | The BMJ

The application to the U.S. Food and Drug Administration (FDA) comes just days after Pfizer and German partner BioNTech SE <22UAy.DE> <BNTX.O> reported final trial results that showed the vaccine was 95% effective in preventing COVID-19 with no major safety concerns. Pfizer Chief Executive Officer Albert Bourla confirmed the application had been made in a video posted on the company's website on Friday afternoon.The application to the U.S. Food and Drug Administration (FDA) comes just days after Pfizer and German partner BioNTech SE <22UAy.DE> <BNTX.O> reported final trial results that showed the vaccine was 95% effective in preventing COVID-19 with no major safety concerns. Pfizer Chief Executive Officer Albert Bourla confirmed the application had been made in a video posted on the company's website on Friday afternoon.

Pfizer files COVID-19 vaccine application to U.S. FDA

Huge logistical task looms when drugs ready since double doses needed for most peopleHuge logistical task looms when drugs ready since double doses needed for most people

What we know so far about Covid-19 vaccines and availability

Most of all: When can you get it into your arm?Most of all: When can you get it into your arm?

Coronavirus Vaccine News | When Will the COVID Vaccine Be Available? | GQ

Since the announcement two weeks ago by the pharmaceutical giant Pfizer that it has successfully tested a vaccine for COVID-19 that is both safe and efficacious, hopes for an end to the pandemic have risen. Pfizer reported an efficacy rate of more than 90 percent. A week later, Moderna, a smaller company, followed suit, claiming […]

While waiting for the vaccine | Inquirer Opinion

Catch up on the most important updates from this week.Catch up on the most important updates from this week.

Pfizer Seeks Vaccine Approval, the CDC Urges Restraint, and More Coronavirus News | WIRED

(WBNG) -- Pfizer and BioNTech have applied for FDA 'emergency use,' after they announced earlier this week that their data showed the vaccine to be 95% effective. So, what does "emergency use" mean? A local Broome County doctor, Dr. Capin, with Lourdes explains. Dr. Capin says usually, certain drugs and vaccines could take up to

Pfizer applied for FDA emergency use; but what does that mean?

BUENOS AIRES, Nov 21 — US drugmaker Pfizer Inc is hoping to rapidly roll out its experimental Covid-19 vaccine around Latin America soon after it gets emergency authorisation in the United States, a senior executive said, which could be as early as next month. Alejandro Cané, the North America...BUENOS AIRES, Nov 21 — US drugmaker Pfizer Inc is hoping to rapidly roll out its experimental Covid-19 vaccine around Latin America soon after it gets emergency authorisation in the United States, a senior executive said, which could be as early as next month. Alejandro Cané, the North America...

Pfizer eyes rapid Covid-19 vaccine roll-out in Latam after US go-ahead | World | Malay Mail

Pfizer / BioNTech’s and Moderna’s vaccines both require two doses, which is common for many vaccines. Multiple doses gives the immune system the opportunity to produce a specific and effective response.Two doses will help ensure the most effective immune response

The first COVID-19 vaccines will likely require two shots - The Verge

Pfizer will apply for emergency permission to distribute its covid-19 vaccine in the US and is ready to start shipping the shots within “hours” of getting a government green light, the firm said today. It is the first such application from any of the makers of covid-19 vaccines that are currently in development. If it…Pfizer will apply for emergency permission to distribute its covid-19 vaccine in the US and is ready to start shipping the shots within “hours” of getting a government green light, the firm said today. It is the first such application from any of the makers of covid-19 vaccines that are currently in development. If it…

A World Health Organization panel says remdesivir does not improve mortality and should not be used in hospitalized Covid-19 patients.A World Health Organization panel says remdesivir does not improve mortality and should not be used in hospitalized Covid-19 patients.

Pfizer to ask today for emergency-use status for Covid-19 vaccine - STAT